Talcum Powder Lawsuit: Ovarian Cancer & Mesothelioma Claims

Millions of women used talcum-based baby powder for personal hygiene for decades. Thousands now allege the talc — contaminated with asbestos, plaintiffs say — caused their ovarian cancer or mesothelioma. Here is where the litigation against Johnson & Johnson and Kenvue stands and how to check if you may qualify.

What Is Talcum Powder and Why Is It Being Sued Over?

Talcum powder is a cosmetic and personal-hygiene product made from talc, a naturally occurring mineral. Johnson & Johnson sold talc-based baby powder for over a century before halting U.S. sales in 2020 and discontinuing it globally in 2023; the consumer-health business, including responsibility for the litigation, was spun off into Kenvue in 2023.

Plaintiffs allege two related but distinct types of harm. The first, and largest, group alleges that regular perineal (genital) use of talc-based powder for feminine hygiene is associated with an increased risk of ovarian cancer. The second group alleges that the talc itself was contaminated with asbestos — a known human carcinogen — and that inhaling or otherwise being exposed to that talc caused mesothelioma, a cancer of the lining of the lungs, abdomen, or heart typically linked to asbestos exposure.

J&J and Kenvue dispute that their talc products caused cancer and maintain that independent testing has repeatedly found their talc asbestos-free. The litigation turns substantially on that scientific and testing dispute, along with what the companies knew about contamination risk and when.

Who May Qualify for a Talcum Powder Lawsuit?

You may have grounds for a claim if you used talc-based baby powder or a similar talc product regularly over an extended period and were later diagnosed with ovarian cancer or mesothelioma. Plaintiff attorneys generally look for:

• Documented, regular use — typically years of repeated use, such as daily or near-daily application for feminine hygiene, or occupational/household exposure to talc-containing products.
• A confirmed diagnosis — ovarian cancer (including epithelial ovarian cancer, the subtype most studied in this litigation) or mesothelioma.
• A plausible exposure-to-diagnosis timeline — meaningful exposure occurring years before diagnosis, consistent with the latency period for these cancers.

Purchase history, product packaging, or a personal history of buying and using talc-based powders can help document exposure. Medical records confirming your specific cancer diagnosis and pathology are the foundation of any claim.

Current MDL Status

Federal talcum powder cases are consolidated as In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, MDL No. 2738, in the U.S. District Court for the District of New Jersey before Judge Michael A. Shipp. As of July 2026, more than 68,000 cases were pending in the federal MDL, making it one of the largest product-liability MDLs in the country — alongside a substantial number of additional cases in New Jersey state court.

J&J has attempted three times to resolve the litigation through a "Texas Two-Step" bankruptcy maneuver — spinning off a subsidiary to absorb the talc liability, then placing that subsidiary into Chapter 11. Courts rejected each attempt, most recently in March 2025, finding the strategy was not a good-faith bankruptcy filing. Notable individual verdicts have continued in the meantime, including a 2026 jury award of $45 million to the family of Theresa Garcia, who died of mesothelioma her family alleged was linked to J&J baby powder use.

The Proposed $5.5 Billion Settlement

In July 2026, J&J announced it had reached an agreement in principle to settle tens of thousands of talcum powder lawsuits for $5.5 billion, with roughly $3 billion of that intended to be paid out as soon as 2027. The settlement is not yet final. Under its terms, it can only proceed if at least 95% of plaintiffs in the remaining claims agree — a high bar that reflects the failed bankruptcy attempts and plaintiffs' firms' resulting skepticism of any deal that isn't court-tested through the ordinary claims process.

No official per-claimant payout figures have been published, and none should be assumed until the settlement is finalized and a claims-administration process with a point matrix is established — the same structure used in comparable mass torts like Roundup and AFFF. Because this settlement's status can change between when this page was last reviewed and when you read it, confirm the current status, including whether the 95% threshold has been met, with a plaintiff attorney before assuming any outcome applies to you.

Mass Tort vs. Class Action

Talcum powder claims are litigated as mass torts, not a single class action — each plaintiff's case and damages are evaluated individually, even within a global settlement like the one described above. That structure is why any eventual per-claimant payments will vary based on diagnosis severity, documented exposure history, and age. See our full mass torts hub and our plain-language guide to what is a mass tort for how this compares to a traditional class action.

How to Start a Talcum Powder Claim

Step 1: Confirm Your Diagnosis

A confirmed ovarian cancer or mesothelioma diagnosis from your treating physician or oncologist is the foundation of any claim. Gather pathology reports, oncology notes, and treatment records.

Step 2: Document Your Exposure History

Reconstruct when, where, and how often you used talc-based baby powder or similar products — purchase history, product packaging you may still have, and the duration and frequency of use all help.

Step 3: Check Your Eligibility and Speak with an Attorney

Use our free eligibility check tool for a preliminary read on whether your situation matches the criteria attorneys are currently evaluating, then speak with a mass tort attorney about where your case stands given the pending settlement and the 95%-threshold requirement. Most talcum powder attorneys work on contingency — no upfront cost, and a fee only if your case recovers.

Statute of Limitations

Every talcum powder claim is subject to a state statute of limitations — typically two to three years from your diagnosis date or from when you reasonably should have connected your illness to talc use, depending on your state's discovery rule. Given the pending settlement's 95%-opt-in requirement and the litigation's long, contested history, waiting to evaluate your claim carries real risk on top of the ordinary filing deadline. Speak with an attorney promptly to understand how these developments affect your specific timeline.

Frequently Asked Questions

Is the talcum powder lawsuit settlement final?

Not yet, as of this page's last update. J&J announced a proposed $5.5 billion settlement in July 2026, but it can only proceed if at least 95% of plaintiffs in the remaining claims agree to the terms. Confirm the current status with an attorney before assuming a specific outcome applies to your case.

How much is a talcum powder lawsuit worth?

No official per-claimant payout figures have been published for the pending settlement. Individually litigated cases have in the past produced verdicts ranging widely, including multimillion-dollar mesothelioma awards, but those are not typical outcomes and depend heavily on case-specific facts. An attorney can give you a realistic assessment based on your diagnosis and exposure history.

Do I need a lawyer to file a talcum powder claim?

You are not legally required to hire an attorney, but nearly all talcum powder attorneys work on contingency — no upfront cost, and a fee only if you recover. Given the litigation's long history of contested bankruptcy maneuvers and the pending settlement's conditions, an attorney is especially important to tell you where your claim currently stands.

What is the difference between the ovarian cancer and mesothelioma claims?

Ovarian cancer claims allege that regular perineal use of talc-based powder itself increased cancer risk. Mesothelioma claims allege the talc was contaminated with asbestos and that exposure to that asbestos caused the cancer. Both are part of the same MDL, but the medical evidence and causation arguments differ — an attorney can tell you which track applies to your diagnosis.

Is talcum powder still sold today?

Johnson & Johnson halted U.S. sales of its talc-based baby powder in 2020, switching to a cornstarch-based formula, and stopped selling talc-based powder globally in 2023. This does not affect eligibility for claims based on past use.